The most important numbers to know about Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) shares traded 0.26% higher at $27.43 on Wall Street last session. PFE stock price is now -0.34% away from the 50-day moving average and -13.86% away from the 200-day moving average. The market capitalization of the company currently stands at $154.89B. On February 23, 2024, Guggenheim recently initiated its ‘Buy’ rating on […]

Pfizer Inc. (NYSE:PFE) Risks You Should Know Before Investing

The price of Pfizer Inc. (NYSE:PFE) shares last traded on Wall Street fell -0.79% to $27.72. PFE stock price is now 0.10% away from the 50-day moving average and -13.67% away from the 200-day moving average. The market capitalization of the company currently stands at $156.53B. With the price target of $36, Guggenheim recently initiated […]

Do investors have a safe investment in Pfizer Inc. (NYSE:PFE)?

The price of Pfizer Inc. (NYSE:PFE) shares last traded on Wall Street fell -0.49% to $28.64. Based on available information, 25 analysts follow Pfizer Inc. (NYSE:PFE). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $75.00 and a low of $32.00, we […]

What is Pfizer Inc.’s (NYSE:PFE) current market value? Can you beat the fundamentals?

In yesterday’s Wall Street session, Pfizer Inc. (NYSE:PFE) shares traded at $29.28, up 1.28% from the previous session. 25 analysts cover Pfizer Inc. (NYSE:PFE), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $75.00 and a low of […]

Reasons why Pfizer Inc.’s (NYSE:PFE) fundamentals are futile

In yesterday’s Wall Street session, Pfizer Inc. (NYSE:PFE) shares traded at $30.14, down -1.18% from the previous session. 26 analysts cover Pfizer Inc. (NYSE:PFE), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $75.00 and a low of […]

Pfizer Inc. (PFE) Holding Strong: What’s pushing it?

In yesterday’s Wall Street session, Pfizer Inc. (NYSE:PFE) shares traded at $29.98, up 0.20% from the previous session. 25 analysts cover Pfizer Inc. (NYSE:PFE), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $75.00 and a low of […]

There’s Still Time to Buy Pfizer Inc. (NYSE:PFE) Stock

In yesterday’s Wall Street session, Pfizer Inc. (NYSE:PFE) shares traded at $28.98, down -1.70% from the previous session. 26 analysts cover Pfizer Inc. (NYSE:PFE), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $75.00 and a low of […]

Do futuristic bulls still own Pfizer Inc. [PFE] stock?

Pfizer Inc. (NYSE:PFE) shares traded -0.26% lower at $31.18 on Wall Street last session. In accordance with the data, 26 analysts cover Pfizer Inc. (NYSE:PFE). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $75.00 and a low of $32.00, we find […]

A secret that hides Pfizer Inc.’s strength (NYSE:PFE)

Stocks of Pfizer Inc. (NYSE:PFE) traded higher last session on Wall Street, up 1.46% to $30.55. According to the data, Pfizer Inc. (NYSE:PFE) has 26 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $75.00 and a low […]

The most important numbers to know about Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) shares traded 0.62% higher at $30.84 on Wall Street last session. In accordance with the data, 26 analysts cover Pfizer Inc. (NYSE:PFE). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $75.00 and a low of $32.00, we find […]